Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
12.78
-0.78 (-5.75%)
At close: Jan 8, 2026, 4:00 PM EST
13.25
+0.47 (3.68%)
Pre-market: Jan 9, 2026, 8:13 AM EST
Vor Biopharma Market Cap
Vor Biopharma has a market cap or net worth of $494.84 million as of January 9, 2026. Its market cap has increased by 730.82% in one year.
Market Cap
494.84M
Enterprise Value
327.44M
1-Year Change
730.82%
Ranking
Category
Stock Price
$12.78
Market Cap Chart
Since the IPO on February 5, 2021, Vor Biopharma's market cap has decreased from $1.30B to $494.84M, a decrease of -61.91%. That is a compound annual growth rate of -17.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 494.84M | -2.29% |
| Dec 31, 2025 | 506.46M | 266.35% |
| Dec 31, 2024 | 138.24M | -9.38% |
| Dec 29, 2023 | 152.56M | -65.05% |
| Dec 30, 2022 | 436.57M | 0.75% |
| Dec 31, 2021 | 433.30M | -66.64% |
| Feb 5, 2021 | 1.30B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 971.66B |
| Johnson & Johnson | 495.71B |
| AbbVie | 396.12B |
| UnitedHealth Group | 314.19B |
| AstraZeneca | 295.31B |
| Merck & Co. | 275.48B |
| Novartis AG | 273.11B |
| Novo Nordisk | 256.73B |